Elucid
4 known investors
Find your way into Elucid
Elucid develops artificial intelligence technology that analyzes CT images to identify hidden features of cardiovascular risk and guide personalized treatment of coronary artery disease. The platform enables physicians to create detailed disease maps and deliver personalized care based on individual patient anatomy.
Investors · 4
Funding
SEC filings, press & company announcements$110M disclosed across 2 rounds · 2026
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Elucid raises $55M to commercialize cardiovascular imaging platform | MedTech Divemedtechdive.com · Sep 2026
Elucid Closes $55M Series D for Heart-Scan AI | Pomegra Startupspomegra.io · Sep 2026
Elucid Series D Funding 2026 — Best Heart Scan Deal Revealedbeststartup.us · Sep 2026
Elucid raises $55m to advance cardiovascular diagnostic portfoliofinance.yahoo.com · Sep 2026
Elucid Raises $55 Million in Oversubscribed Series D Financing | Elucidelucid.com · Sep 2026Frequently asked questions
- What does Elucid do?
- Elucid develops artificial intelligence technology that analyzes CT images to identify hidden features of cardiovascular risk and guide personalized treatment of coronary artery disease. The platform enables physicians to create detailed disease maps and deliver personalized care based on individual patient anatomy.
- Who are Elucid's investors?
- Elucid's investors include Angel Physicians Fund, Aphelion Capital, BlueStone Venture Partners, IAG Capital Partners.
- How much funding has Elucid raised?
- Elucid has disclosed $110M raised across 2 rounds.